Provided by Tiger Trade Technology Pte. Ltd.

Chaince Digital Holdings Inc.

3.59
+0.20005.90%
Post-market: 3.590.00000.00%19:30 EDT
Volume:187.76K
Turnover:674.89K
Market Cap:394.90M
PE:-55.12
High:3.80
Open:3.38
Low:3.36
Close:3.39
52wk High:36.77
52wk Low:2.10
Shares:110.00M
Float Shares:87.22M
Volume Ratio:0.69
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0651
EPS(LYR):-0.0772
ROE:-7.73%
ROA:-6.37%
PB:8.44
PE(LYR):-46.51

Loading ...

Chaince Digital Holdings Falls To US$7.39, But Insiders Sold At Lower Price

Simply Wall St.
·
May 24

Chaince Digital CSO Wilfred ZhongKei Daye sells $77,267.76 in common shares

Reuters
·
May 22

Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease

prnewswire
·
May 18

CD Projekt SA (OTGLF) Receives a Sell from Goldman Sachs

TIPRANKS
·
May 18

I have $310,000 in cash from a maturing CD. Where should I put it next?

Dow Jones
·
May 17

Chaince Q1 FY26 net loss widens 3.92% to $1.35 million; revenue rises to $507,546

Reuters
·
May 15

Press Release: Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 14

I have $310,000 in cash from a maturing CD. Where should I put it next?

Dow Jones
·
May 13

I have $310,000 in cash from a maturing CD. Where should I put it next?

Dow Jones
·
May 11

Dongguan's Richest Family Secures $19 Billion Computing Power Contract: Golden Opportunity or Financial Pitfall?

Deep News
·
May 07

Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis

GlobeNewswire
·
May 05

Cocrystal Showcases Norovirus Candidate CDI-988 at ICAR 2026

TIPRANKS
·
May 01

Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors

GlobeNewswire
·
Apr 30

Press Release: Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution

Dow Jones
·
Apr 29

Press Release: RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights

Dow Jones
·
Apr 27

SOLAI receives revised going-private proposal from Chaince Digital at US$3.16 per ADS

Reuters
·
Apr 23

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

GlobeNewswire
·
Apr 20

Reviving Secondhand Treasures: Where Memories Find New Life

Deep News
·
Apr 20

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

GlobeNewswire
·
Apr 19

Guangdong Hec Technology Reports 600 Million Yuan Stock Trading Loss, Interest-Bearing Debt Soars to 15.5 Billion Yuan After Qinhuai Data Acquisition

Deep News
·
Apr 18